GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Tsuruha Holdings Inc (TSE:3391) » Definitions » Debt-to-EBITDA

Tsuruha Holdings (TSE:3391) Debt-to-EBITDA : 0.96 (As of Feb. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Tsuruha Holdings Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Tsuruha Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2024 was 円8,570 Mil. Tsuruha Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2024 was 円42,859 Mil. Tsuruha Holdings's annualized EBITDA for the quarter that ended in Feb. 2024 was 円53,532 Mil. Tsuruha Holdings's annualized Debt-to-EBITDA for the quarter that ended in Feb. 2024 was 0.96.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Tsuruha Holdings's Debt-to-EBITDA or its related term are showing as below:

TSE:3391' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.01   Med: 0.22   Max: 1.1
Current: 1.1

During the past 13 years, the highest Debt-to-EBITDA Ratio of Tsuruha Holdings was 1.10. The lowest was 0.01. And the median was 0.22.

TSE:3391's Debt-to-EBITDA is ranked better than
67.93% of 421 companies
in the Healthcare Providers & Services industry
Industry Median: 2.58 vs TSE:3391: 1.10

Tsuruha Holdings Debt-to-EBITDA Historical Data

The historical data trend for Tsuruha Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tsuruha Holdings Debt-to-EBITDA Chart

Tsuruha Holdings Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.21 0.65 1.05 0.90

Tsuruha Holdings Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.02 2.39 0.93 0.96 0.96

Competitive Comparison of Tsuruha Holdings's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, Tsuruha Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tsuruha Holdings's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tsuruha Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Tsuruha Holdings's Debt-to-EBITDA falls into.



Tsuruha Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Tsuruha Holdings's Debt-to-EBITDA for the fiscal year that ended in May. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(11403 + 43460) / 61311
=0.89

Tsuruha Holdings's annualized Debt-to-EBITDA for the quarter that ended in Feb. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(8570 + 42859) / 53532
=0.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Feb. 2024) EBITDA data.


Tsuruha Holdings  (TSE:3391) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Tsuruha Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Tsuruha Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Tsuruha Holdings (TSE:3391) Business Description

Traded in Other Exchanges
Address
20, Higashi 24-chome, Higashi Sapporo 1-21, Kitaku, JPN, 065-0024
Tsuruha Holdings Inc manages pharmaceutical companies in Japan, where the drugstore business is the core of their operations. The company generates revenue through selling prescription and over-the-counter drugs, medical supplies, nursing care products, discount cosmetics, health products, and a miscellaneous assortment of general merchandise. Tsuruha also provides blood testing services, disease prevention solutions, and at-home drug delivery services.

Tsuruha Holdings (TSE:3391) Headlines

No Headlines